drugset / Trial / NCT00901381
Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke
Phase 2
Completed
20 enrolled
Clinical Institute of the Brain, Russia
City Hospital No 40, Saint Petersburg, Russia · collabInstitute of Medical Cells Technologies · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of the study is to investigate treatment with Leukostim (Filgrastim; granulocyte-colony stimulating factor; G-CSF) for acute ischemic stroke.
Timeline
- Start
- 2007-06
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | filgrastim | Protein / enzyme biologic | 10 ug/kg | Subcutaneous |